6 May 2025 (Tuesday)
At 06:30 PM Central Time (US and Canada)
This live, CME-accredited webinar explores current and emerging applications of insertable cardiac monitors (ICMs) in the management of cardiovascular disease. Led by a distinguished panel of electrophysiologists and stroke specialists, the program will highlight how ICMs support the detection and monitoring of arrhythmias, guide risk stratification, and play a critical role in long-term disease management.
Through concise expert-led presentations and an extended interactive panel discussion, attendees will gain insight into ICM technology advancements, patient selection strategies, and clinical implementation. The session will also examine real-world case applications and evidence to help translate data into actionable practices that improve patient outcomes.
1. Describe the utility of ICMs in detecting and managing ventricular arrhythmias, atrial fibrillation, and cryptogenic stroke.
2. Discuss advancements in ICM technology, including device durability, longevity, and features that support continuous monitoring.
3. Review the clinical indications for ICM use across different stages of AF management, particularly in pre- and post-ablation settings.
4. Apply ICMs to real-world practice, particularly for arrhythmia burden quantification, long-term risk assessment, and stroke prevention.
5. Evaluate evidence from landmark trials, including CRYSTAL AF and DIVERT Stroke, to inform guideline-concordant monitoring strategies
Director of the Program
Speaker
Ventricular Arrhythmias, Risk Stratification, Arrhythmia Burden Quantification and Disease Management with ICMs
Speaker
Mastering Longevity and Features: Exploring the Durability of ICMs
Speaker
Evolution of Implantable Cardiac Monitoring Technology and Indications for Use.
Speaker
ICMs in AF Disease Management: Evidence Behind ICM Utility Before and After AF Ablation.
Speaker
Cryptogenic Stroke and the Role of ICM: Lessons from CRYSTAL AF and DIVERT Stroke.
Speaker
Ventricular Arrhythmias, Risk Stratification, Arrhythmia Burden Quantification and Disease Management with ICMs
Speaker
Mastering Longevity and Features: Exploring the Durability of ICMs
Speaker
Evolution of Implantable Cardiac Monitoring Technology and Indications for Use.
Speaker
ICMs in AF Disease Management: Evidence Behind ICM Utility Before and After AF Ablation.
Speaker
Cryptogenic Stroke and the Role of ICM: Lessons from CRYSTAL AF and DIVERT Stroke.
Quantifying arrhythmia burden and using ICMs to enhance disease management pathways
Examining device performance, longevity, and technical features that support clinical utility
Reviewing the evolution of ICM technology and current indications in cardiology and stroke care
Exploring evidence behind the integration of ICMs in AF ablation workflows
Analyzing data from major clinical trials that have shaped the contemporary use of ICMs
